poorly differentiated thyroid gland carcinoma
Showing 1 - 7 of 7
Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston
Recruiting
- Malignant Thyroid Gland Neoplasm
- +6 more
- Quality-of-Life Assessment
- +3 more
-
Ann Arbor, Michigan
- +1 more
Jan 24, 2023
Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic
Active, not recruiting
- Columnar Cell Variant Thyroid Gland Papillary Carcinoma
- +25 more
- Laboratory Biomarker Analysis
- +3 more
-
Torrance, California
- +6 more
Jan 12, 2023
Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)
Recruiting
- Bone Sarcoma
- +15 more
- Aldesleukin
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)
Terminated
- Thyroid Cancer
- +5 more
- Lenvatinib
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021
Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Thyroid Gland Anaplastic Carcinoma by AJCC V8
Suspended
- Metastatic Thyroid Gland Carcinoma
- +2 more
- Lenvatinib
- +2 more
-
Saint Petersburg, Russian FederationSaint-Petersburg State University (SPSU) N.I.Pirogov Clinic of H
May 13, 2021
Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Follicular Carcinoma
Completed
- Poorly Differentiated Thyroid Gland Carcinoma
- +15 more
- Cabozantinib S-malate
- Laboratory Biomarker Analysis
-
Washington, District of Columbia
- +6 more
Mar 7, 2018